HART

IndexIQ Introduces ETF Suite Focused on Leaders in Research & Development

Retrieved on: 
Tuesday, February 8, 2022
Banking, Professional Services, Insurance, Finance, Industry, Growth, FTSE Russell, ETF, Time, Mackay, Funding, WRND, Investment, Twitter, Risk, Fund, ESG, Index, Investment Company Act of 1940, Review, New York Life Insurance Company, Russell, Prospectus, ALPS, QAI, FTSE, Hudson Street, Research and Development Expenditure Credit, IQ, New York Life Investments, HART, MRND, LinkedIn, FTSE Group, Accounting, Russell Midcap Index, R, LLC, Marble, Financial adviser, Life insurance, Security (finance), Bank, Research

The R&D ETF suite joins a multi-asset family of cutting-edge ETFs from IndexIQ that includes the IQ Hedge Multi-Strategy ETF (QAI), the first liquid alternative ETF; innovative fixed income offerings like the IQ MacKay ESG Core Plus Bond ETF (ESGB); and the firms Dual Impact ETF suite, which includes IQ Healthy Hearts ETF (HART), IQ Engender Equality ETF (EQUL), IQ Cleaner Transport ETF (CLNR), and IQ Clean Oceans ETF (OCEN).

Key Points: 
  • The R&D ETF suite joins a multi-asset family of cutting-edge ETFs from IndexIQ that includes the IQ Hedge Multi-Strategy ETF (QAI), the first liquid alternative ETF; innovative fixed income offerings like the IQ MacKay ESG Core Plus Bond ETF (ESGB); and the firms Dual Impact ETF suite, which includes IQ Healthy Hearts ETF (HART), IQ Engender Equality ETF (EQUL), IQ Cleaner Transport ETF (CLNR), and IQ Clean Oceans ETF (OCEN).
  • Mid Cap R&D Leaders Index, IQ U.S. Large Cap R&D Leaders Index and IQ Global Equity R&D Leaders Index, respectively.
  • Mid Cap R&D Leaders ETF, IQ U.S. Large Cap R&D Leaders ETF and IQ Global Equity R&D Leaders ETF.
  • Mid Cap R&D Leaders Index, IQ U.S. Large Cap R&D Leaders Index and IQ Global Equity R&D Leaders Index.

American Medical Association (AMA) Grants Prevencio Three CPT® PLA Reimbursement Codes for Novel AI-driven Cardiac HART® Blood Tests

Retrieved on: 
Tuesday, January 11, 2022
Professional Services, Health, Medical Devices, Technology, Other Technology, Insurance, Cardiology, American Heart Association, European Society of Cardiology, Laboratory developed test, Risk assessment, Stroke, Journal, LDT, Degenerative disease, Population, Adult, Kawasaki disease, Death, Machine learning, Indian Medical Association, Medicaid, Cardiology, Kawasaki, AMA, The American Journal of Cardiology, PLA, American Medical Association, Cardiovascular disease, Artificial intelligence, Heart, Company, HART, American College of Cardiology, Clinical Cardiology, Arrest, Diagnosis, Biomarker, AI, Congress, Risk, Algorithm, Medical device, Medicine, Prevencio HART Tests, Prevencio, Inc., PREVENCIO HART TESTS, PREVENCIO, INC.

The codes were included in the revised set of PLA codes the AMA released on December 30, 2021, with effective dates of April 1, 2022.

Key Points: 
  • The codes were included in the revised set of PLA codes the AMA released on December 30, 2021, with effective dates of April 1, 2022.
  • The AMA assigned the new code 0308U for HART CADhs, 0309U for HART CVE, and 0310U for HART KD.
  • These CPT PLA codes are a critical step in our efforts to secure reimbursement from individual employer-sponsored, commercial, and Medicaid health plans.
  • For additional information on Prevencios HART Tests, visit Prevencio, Inc.
    About Prevencio HART Tests: Powered by AI, Prevencio is revolutionizing blood tests for cardiovascular disease and custom diagnostics.

HART joins Vacations Coin to Implement Crypto Useability across Hospitality Sector

Retrieved on: 
Saturday, December 18, 2021
Crypto, HART, Hospitality industry, Growth, LVC, Block, Hospital information system, Partnership, Cryptocurrency, Industry, Hospitality

LONDON, Dec. 18, 2021 /PRNewswire-PRWeb/ --HART is proud to announce that we are partnering with Hospitality's first Cryptocurrency Vacations Coin.

Key Points: 
  • LONDON, Dec. 18, 2021 /PRNewswire-PRWeb/ --HART is proud to announce that we are partnering with Hospitality's first Cryptocurrency Vacations Coin.
  • As an Early Affiliate Partner, HART will be working together with LVC Hub to enable the useability of Vacations Coin within the Hospitality Industry.
  • The Global Hospitality Industry is a Multi-Trillion-Dollar sector and as Vacations Coin is only releasing a limited number of tokens, the possibility for growth is exponential.
  • Spyros Botsis (HART Director) announced, "We are extremely excited to work together with LVC on Vacations Coin Hospitality implementation.

Ramo Law PC's Alexa Whiteside Selected as Leader in Law Award Nominee

Retrieved on: 
Tuesday, November 30, 2021
CJ Entertainment, THE, LOL, CEO, Time, Industry, HART, Award, North Carolina Bar Association, Sport, Sirius XM, Partnership, Wills, The Film Department, Private law, Music, HEART, Los Angeles Business Journal, Education, MDA, Program, FATAL, NASCAR, ALI, Fine Arts Films, Sundance, Kevin Hart, Chairperson, New York University School of Law, LLC, WOMEN, Entertainment law, Alumnus, Asa, Journal, DIE, Creative Artists Agency, Radio, Netflix, Lawyer, Television, Line, Company, Video game, Film

LOS ANGELES, Nov. 30, 2021 /PRNewswire/ --Entertainment law firm Ramo Law PC announced today that attorney Alexa Whiteside has been selected asa nominee for the Los Angeles Business Journal's 2021 ' Leaders in Law Awards .

Key Points: 
  • LOS ANGELES, Nov. 30, 2021 /PRNewswire/ --Entertainment law firm Ramo Law PC announced today that attorney Alexa Whiteside has been selected asa nominee for the Los Angeles Business Journal's 2021 ' Leaders in Law Awards .
  • Whiteside joined Ramo Law after graduating magna cum laude from Southwestern Law School in Los Angeles and is also an alumnus of New York University's Tisch School of the Arts Film & Television Department.
  • She's also an avid copyright and personal rights geek, providing a particular focus and expanding the firm's work in clearances, licensing, and fair use.
  • She serves as outside general counsel for production companies such as Kevin Hart's production and distribution companies Laugh Out Loud!

Prevencio’s AI-driven HART CADhs Blood Test Significantly More Accurate than Troponin for Heart Disease Diagnosis in Diabetic Patients

Retrieved on: 
Tuesday, November 16, 2021
Health, Technology, Diabetes, Hospitals, Other Technology, Cardiology, Population, American Diabetes Association, European Society of Cardiology, Artificial intelligence, MD, Algorithm, American College of Cardiology, Degenerative disease, Heart, Congress, Troponin, Arrest, Stroke, Diabetes, Machine learning, AI, Cardiovascular disease, Massachusetts General Hospital, The American Journal of Cardiology, Company, Risk assessment, Cardiology, Journal, Diagnosis, Death, Macrotritopus defilippi, HART, Hamburg, Patient, Risk, Biomarker, American Heart Association, Clinical Cardiology, Pharmaceutical industry, Medical device, Prevencio HART Tests, Prevencio, Inc., PREVENCIO HART TESTS, PREVENCIO, INC.

Prevencio, Inc. today announces the presentation of multinational patient data demonstrating its HART CADhs blood test is significantly more accurate than high sensitivity troponin in determining whether a diabetic patient has obstructive heart disease.

Key Points: 
  • Prevencio, Inc. today announces the presentation of multinational patient data demonstrating its HART CADhs blood test is significantly more accurate than high sensitivity troponin in determining whether a diabetic patient has obstructive heart disease.
  • Cardiologists from Inova Heart and Vascular Institute, Massachusetts General Hospital, and University Heart Center of Hamburg Germany collaborated to test diabetic patients for blood diagnosis of heart disease.
  • Diabetic patients are twice as likely to have heart disease compared to nondiabetic patients and require regular monitoring.
  • In addition to the HART CADhs blood test for heart disease and imminent risk of heart attack, Prevencio recently launch a second multiprotein blood test, HART CVE, for one-year risk of heart attack, stroke, or cardiac death.

Prevencio and Seattle Children’s Research Institute Present Highly Accurate, AI-driven HART KD Data on First Blood Test for Kawasaki Disease at Premiere International Kawasaki Disease Scientific Sessions  

Retrieved on: 
Tuesday, November 9, 2021
Infectious Diseases, Children, General Health, Health, European Society of Cardiology, Congress, Heart, Machine learning, Diagnosis, HART, KD, Risk, American Heart Association, Artificial intelligence, Kawasaki disease, The American Journal of Cardiology, Cardiology, Fever, FDA, Clinical Cardiology, American College of Cardiology, Degenerative disease, Disease, Rash, Arrest, Stroke, AI, Aneurysm, Protein, Journal, Sudden death, University, MD, Pediatrics, Algorithm, Incidence, University of Washington School of Medicine, Infarction, Cardiovascular disease, Company, Risk assessment, Seattle, Biomarker, Intellectual property, Medical device, Vaccine, Pharmaceutical industry

Prevencio, Inc. today announces presentation of highly accurate data on an Artificial Intelligence (AI)-driven blood test for Kawasaki disease (KD) at the International Kawasaki Disease Scientific Sessions in Japan.

Key Points: 
  • Prevencio, Inc. today announces presentation of highly accurate data on an Artificial Intelligence (AI)-driven blood test for Kawasaki disease (KD) at the International Kawasaki Disease Scientific Sessions in Japan.
  • The novel test, HART KD, was jointly developed with Seattle Childrens Research Institute and leveraged Prevencios AI-driven HART platform and expertise in developing novel AI-driven blood tests.
  • HART KD provides a long-needed, diagnostic blood test to distinguish KD from common infectious and inflammatory conditions.
  • Kawasaki disease is the most common acquired heart disease in children and occurs mostly in children younger than 5 years old.

Taiwantrade.com Launches Online Showcase of Consumer Electronics

Retrieved on: 
Sunday, November 7, 2021
Technology, Retail, Online Retail, Consumer Electronics, Online, TFT LCD, Electronics, Router (computing), Intelligence, HART, CORAL, CarPlay, Multimedia, TFT, Online shopping

Taiwantrade.com is presenting a Consumer Electronics Online Showcase for buyers all over the world starting October 2021 through January 2022.

Key Points: 
  • Taiwantrade.com is presenting a Consumer Electronics Online Showcase for buyers all over the world starting October 2021 through January 2022.
  • Among the featured products are portable CarPlay, Bluetooth audio mixer and 5G WIFI Router, the showcase presents the most advanced consumer electronics products.
  • View the full release here: https://www.businesswire.com/news/home/20211106005001/en/
    Taiwantrade.com launches online showcase of consumer electronics (Photo: Business Wire)
    Taiwan plays an integral part of the global consumer electronics supply chain and is a producer of a wide variety of consumer electronics goods.
  • Visit the online showcase at https://ict.taiwantrade.com for a comprehensive list of all excellent offers from Taiwans quality consumer electronics manufactures.

Azbil Introduces Smart HART Modem Model AZ-1SHM With Power Supply Function for Fast Resolution of Communication Problems in Field Devices

Retrieved on: 
Thursday, October 28, 2021
Other Manufacturing, Mobile, Wireless, Technology, Construction & Property, Other Technology, Telecommunications, Manufacturing, Hardware, Other Construction & Property, Consumer Electronics, Modem, Corporation, Weather, Communication, Bluetooth, Maintenance, Software, Light-emitting diode, Multimedia, Plant, Smart, HART, Instrumentation

View the full release here: https://www.businesswire.com/news/home/20211028005489/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211028005489/en/
    Smart HART Modem model AZ-1SHM (Photo: Business Wire)
    A HART modem is a digital communication interface device for setting up and configuring HART communicationcompliant field devices such as sensors and valves (HART devices), which are installed in large numbers at manufacturing sites.
  • In a new or expanded plant or during shutdown maintenance, maintenance personnel connect a host device via HART modems to HART devices to configure various parameters.
  • In some cases, a problem related to wiring, connection environment, device compatibility or the power supply may prevent a connection.
  • Since the modem can be used with Azbils and other companies HART devices, maintenance workers can safely and quickly handle communication problems using a single 1SHM unit.

Prevencio and Memorial Sloan Kettering Cancer Center Data Demonstrates Significant Correlation of AI-driven HART CVE Blood Test Scores with Development of Adverse Heart Events Following Cancer Radiation Treatment

Retrieved on: 
Wednesday, October 27, 2021
Oncology, Health, Clinical Trials, Radiology, Cardiology, Biotechnology, Proton, Woman, The American Journal of Cardiology, Algorithm, Radiation, Diagnosis, Assistant, Memorial Sloan Kettering Cancer Center, Cancer, 57, Risk assessment, Radiation therapy, Patient, Machine learning, Cardiovascular disease, American Heart Association, Breast, AUC, Congress, Risk, Company, Stroke, Man, Lung cancer, Artificial intelligence, American College of Cardiology, Population, Clinical Cardiology, Heart, European Society of Cardiology, Journal, Cardiology, Biomarker, AI, HART, Arrest, Medical device, Medical imaging

Prevencio, Inc. today announces the presentation of data demonstrating that its Artificial Intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment.

Key Points: 
  • Prevencio, Inc. today announces the presentation of data demonstrating that its Artificial Intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment.
  • Researchers and clinicians from Memorial Sloan Kettering Cancer Center collaborated to test their lung cancer population.
  • We analyzed serial patient blood samples before, during and after radiation treatment and interestingly found a significant correlation between an increase in the HART CVE scores during radiation and the development of cardiac events in follow up after radiation.
  • For additional information, visit Prevencio, Inc.
    About Prevencio HART Tests: Powered by AI, Prevencio is revolutionizing blood tests for cardiovascular disease and custom diagnostics.

Electric Power Systems Acquires H.A.R.T. High Voltage Apparatus Repair and Testing Co.

Retrieved on: 
Tuesday, October 26, 2021
Safety, Engineering, EPS, Service, Electric energy consumption, Industry, Electric power industry, General manager, View, Next-generation network services, Information International, Inc., Standard, Maintenance, NASS, Test (assessment), CEO, NETA, Multimedia, International Electrical Testing Association, Acquisition, Culture, HART, Instrumentation

YUBA CITY, Calif., Oct. 26, 2021 /PRNewswire/ --Electric Power Systems (EPS), one of the largest and fastest growing companies in the independent power system testing and engineering industry, has acquired H.A.R.T.

Key Points: 
  • YUBA CITY, Calif., Oct. 26, 2021 /PRNewswire/ --Electric Power Systems (EPS), one of the largest and fastest growing companies in the independent power system testing and engineering industry, has acquired H.A.R.T.
  • High Voltage Apparatus Repair and Testing Co (HART).
  • About HART High Voltage Apparatus Repair and Testing Co.
    HART was started in Yuba City CA in December of 1991.
  • Their subsidiary Electric Power Systems International Inc (EPSII) is a full member of the International Electrical Testing Association (NETA).